Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Merck’s Calderasib Receives FDA Breakthrough Therapy Designation for Lung Cancer
Merck has secured a significant regulatory milestone for its investigational cancer therapy, calderasib (MK-1084), after the U.S. Food and Drug Administration (FDA) granted the treatment Breakthrough Therapy designation....
MannKind Secures FDA Approval for Afrezza in Pediatric Diabetes
MannKind Corporation has received US Food and Drug Administration (FDA) approval for Afrezza® (insulin human) Inhalation Powder for children and adolescents aged six years and older with type 1 or type 2 diabetes....
VERTANICAL Secures FDA Breakthrough Therapy Status for VER-01 for Chronic Back Pain
VERTANICAL has achieved an important regulatory milestone after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to VER-01, an investigational non-opioid therapy being developed for chronic low back pain....
FDA Approves Regeneron’s First-in-Class Gene Therapy for OTOF Hearing Loss
Regeneron Pharmaceuticals has received FDA accelerated approval (lunsotogene parvec-cwha), a gene therapy for patients with severe-to-profound sensorineural hearing loss caused by OTOF gene mutations....
Galmed Announces Breakthrough Brain-Penetrating Formulation of Aramchol for CNS Disorders
Galmed Pharmaceuticals Ltd. has announced the development of a brain-penetrating formulation of its SCD1 inhibitor, Aramchol, designed for potential use in central nervous system (CNS) diseases including Parkinson’s disease....
Novo Nordisk Receives FDA Approval for Awiqli®, a Once-Weekly Basal Insulin for Type 2 Diabetes
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first once-weekly, long-acting basal insulin for adults with type 2 diabetes....
Unexpected Laboratory Result Opens New Path in Drug Development Chemistry
Scientists at the University of Cambridge have discovered a new light-driven chemical reaction that could make drug development faster and more sustainable....
Johnson & Johnson’s RYBREVANT FASPRO™ Receives FDA Breakthrough Therapy Designation for Advanced Head and Neck Cancer
Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) for adults...
HERNEXEOS Receives FDA Approval for Advanced HER2-Mutant NSCLC
The U.S. Food and Drug Administration has approved HERNEXEOS (zongertinib tablets), developed by Boehringer Ingelheim, for the treatment of adults with advanced non-small cell lung cancer (NSCLC) whose tumours...
Alkermes Secures FDA Breakthrough Therapy Status for Alixorexton in Narcolepsy Type 1
Alkermes plc has announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1)....
